$OFIX
Orthofix Medical Inc. Stock $ofix

$ofix Overview Financials Valuation SEC Filings Company Website

2011 Form 10-K Financial Statement

#000110465912014637 Filed on February 29, 2012

Income Statement

Concept	2011	2010 Q4	2010
Revenue	$442.0M	$143.8M	$460.6M
YoY Change	-4.05%	-0.14%	-15.58%
Cost Of Revenue	$95.53M	$32.70M	$90.46M
YoY Change	5.6%	-10.9%	-34.66%
Gross Profit	$346.4M	$111.1M	$370.2M
YoY Change	-6.41%	3.54%	-9.09%
Gross Profit Margin	78.39%	77.26%	80.36%
Selling, General & Admin	$258.0M	$85.40M	$273.7M
YoY Change	-5.76%	10.05%	-10.19%
% of Gross Profit	74.47%	76.87%	73.95%
Research & Development	$22.86M	$7.100M	$27.96M
YoY Change	-18.23%	26.79%	-11.13%
% of Gross Profit	6.6%	6.39%	7.55%
Depreciation & Amortization	$23.02M	$7.000M	$22.52M
YoY Change	2.2%	12.9%	0.79%
% of Gross Profit	6.64%	6.3%	6.08%
Operating Expenses	$340.5M	$94.00M	$303.9M
YoY Change	12.05%	10.2%	-9.62%
Operating Profit	$5.900M	$17.10M	$66.25M
YoY Change	-91.09%	-22.27%	3.72%
Interest Expense	$5.541M	-$2.100M	$16.22M
YoY Change	-65.83%	-61.11%	-34.66%
% of Operating Profit	93.92%	-12.28%	24.48%
Other Income/Expense, Net	-$7.953M	$500.0K	-$15.89M
YoY Change	-49.94%	-200.0%	-33.4%
Pretax Income	$17.00M	$15.20M	$48.41M
YoY Change	-64.89%	-5.0%	20.95%
Income Tax	$14.17M	$7.300M	$22.61M
% Of Pretax Income	83.34%	48.03%	46.7%
Net Earnings	-$18.11M	$8.000M	$44.21M
YoY Change	-140.97%	-15.79%	80.44%
Net Earnings / Revenue	-4.1%	5.56%	9.6%
Basic Earnings Per Share	-$0.99		$2.51
Diluted Earnings Per Share	-$0.99	$446.9K	$2.47
COMMON SHARES
Basic Shares Outstanding	18.22M shares		17.60M shares
Diluted Shares Outstanding	18.22M shares		17.91M shares

Balance Sheet

Concept	2011	2010 Q4	2010
SHORT-TERM ASSETS
Cash & Short-Term Investments	$33.20M	$13.60M	$13.60M
YoY Change	144.12%	2.26%	2.26%
Cash & Equivalents	$33.20M	$13.56M	$13.60M
Short-Term Investments
Other Short-Term Assets	$92.10M	$64.50M	$64.50M
YoY Change	42.79%	31.9%	31.9%
Inventory	$91.20M	$84.59M	$84.60M
Prepaid Expenses
Receivables	$146.5M	$134.2M	$134.2M
Other Receivables	$41.60M	$14.90M	$14.90M
Total Short-Term Assets	$404.6M	$311.8M	$311.8M
YoY Change	29.76%	4.09%	4.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$52.10M	$45.54M	$45.50M
YoY Change	14.51%	17.66%	17.57%
Goodwill		$73.60M
YoY Change
Intangibles		$41.46M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$21.90M	$12.57M	$28.70M
YoY Change	-23.69%	-35.56%	47.18%
Total Long-Term Assets	$291.0M	$292.2M	$292.2M
YoY Change	-0.41%	0.42%	0.41%
TOTAL ASSETS
Total Short-Term Assets	$404.6M	$311.8M	$311.8M
Total Long-Term Assets	$291.0M	$292.2M	$292.2M
Total Assets	$695.6M	$604.0M	$604.0M
YoY Change	15.17%	2.28%	2.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.10M	$19.80M	$19.80M
YoY Change	1.52%	-15.02%	-15.02%
Accrued Expenses	$126.7M	$0.00	$42.80M
YoY Change	196.03%		-6.96%
Deferred Revenue
YoY Change
Short-Term Debt	$1.300M	$3.800M	$3.800M
YoY Change	-65.79%	72.73%	72.73%
Long-Term Debt Due	$17.50M	$7.500M	$7.500M
YoY Change	133.33%	127.27%	127.27%
Total Short-Term Liabilities	$175.4M	$83.53M	$83.50M
YoY Change	110.06%	-5.19%	-5.22%
LONG-TERM LIABILITIES
Long-Term Debt	$191.2M	$208.7M	$208.7M
YoY Change	-8.39%	-16.22%	-16.22%
Other Long-Term Liabilities	$4.000M	$2.775M	$2.800M
YoY Change	42.86%	-59.78%	-59.42%
Total Long-Term Liabilities	$195.2M	$2.775M	$211.5M
YoY Change	-7.71%	-98.92%	-17.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$175.4M	$83.53M	$83.50M
Total Long-Term Liabilities	$195.2M	$2.775M	$211.5M
Total Liabilities	$380.4M	$303.1M	$303.1M
YoY Change	25.5%	-13.45%	-13.45%
SHAREHOLDERS EQUITY
Retained Earnings		$98.33M
YoY Change
Common Stock		$197.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$315.2M	$300.9M	$300.9M
YoY Change
Total Liabilities & Shareholders Equity	$695.6M	$604.0M	$604.0M
YoY Change	15.17%	2.28%	2.29%

Cashflow Statement

Concept	2011	2010 Q4	2010
OPERATING ACTIVITIES
Net Income	-$18.11M	$8.000M	$44.21M
YoY Change	-140.97%	-15.79%	80.44%
Depreciation, Depletion And Amortization	$23.02M	$7.000M	$22.52M
YoY Change	2.2%	12.9%	0.79%
Cash From Operating Activities	$64.80M	$12.70M	$42.50M
YoY Change	52.47%	-37.13%	-15.0%
INVESTING ACTIVITIES
Capital Expenditures	$24.97M	-$9.200M	$25.84M
YoY Change	-3.4%	55.93%	23.57%
Acquisitions	$5.250M
YoY Change
Other Investing Activities	-$5.300M	$0.00	$24.20M
YoY Change	-121.9%	-100.0%	-8166.67%
Cash From Investing Activities	-$31.01M	-$9.200M	-$2.146M
YoY Change	1344.92%	16.46%	-90.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$20.11M		$7.854M
YoY Change	156.09%		11120.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$13.66M	-5.200M	-$40.03M
YoY Change	-65.86%	-10.34%	33.62%
NET CHANGE
Cash From Operating Activities	64.80M	12.70M	42.50M
Cash From Investing Activities	-$31.01M	-9.200M	-$2.146M
Cash From Financing Activities	-$13.66M	-5.200M	-$40.03M
Net Change In Cash	-$44.67M	-1.700M	-$42.17M
YoY Change	5.93%	-126.15%	-19.28%
FREE CASH FLOW
Cash From Operating Activities	$64.80M	$12.70M	$42.50M
Capital Expenditures	$24.97M	-$9.200M	$25.84M
Free Cash Flow	$39.84M	$21.90M	$16.66M
YoY Change	139.16%	-16.09%	-42.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13561000	USD
CY2010Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	22944000	USD
CY2010Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	134184000	USD
CY2010Q4	us-gaap	Inventory Net InventoryNet	84589000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	17422000	USD
CY2010Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	14937000	USD
CY2010Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24123000	USD
CY2010Q4	us-gaap	Assets Current AssetsCurrent	311760000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45535000	USD
CY2010Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	41457000	USD
CY2010Q4	us-gaap	Goodwill Goodwill	176497000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	16175000	USD
CY2010Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12565000	USD
CY2010Q4	us-gaap	Assets Assets	603989000	USD
CY2010Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	3812000	USD
CY2010Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7500000	USD
CY2011	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2011	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2011
CY2010Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	208695000	USD
CY2011	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2010Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	8102000	USD
CY2010Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2775000	USD
CY2010Q4	us-gaap	Liabilities Liabilities	303098000	USD
CY2010Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	19796000	USD
CY2010Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	52418000	USD
CY2010Q4	us-gaap	Liabilities Current LiabilitiesCurrent	83526000	USD
CY2011	dei	Entity Registrant Name EntityRegistrantName	ORTHOFIX INTERNATIONAL N V
CY2011	dei	Entity Central Index Key EntityCentralIndexKey	0000884624
CY2011	dei	Document Type DocumentType	10-K
CY2011	dei	Document Period End Date DocumentPeriodEndDate	2011-12-31
CY2011	dei	Amendment Flag AmendmentFlag	false
CY2011	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2011	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2011	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2011	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2010Q4	us-gaap	Common Stock Value CommonStockValue	1772000	USD
CY2010Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	195402000	USD
CY2010Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	98327000	USD
CY2010Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5390000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	300891000	USD
CY2010Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	603989000	USD
CY2010Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	695551000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	315171000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	380380000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	175412000	USD
CY2011Q4	us-gaap	Assets Assets	695551000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	404590000	USD
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18465444	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18465444	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2011Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10045000	USD
CY2010Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17726645	shares
CY2010Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17726645	shares
CY2010Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2010Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2010Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7250000	USD
CY2009	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	248000	USD
CY2010	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8746000	USD
CY2009	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7335000	USD
CY2010	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	178000	USD
CY2009	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4409000	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	8138000	USD
CY2009	us-gaap	Share Based Compensation ShareBasedCompensation	10752000	USD
CY2010	us-gaap	Inventory Write Down InventoryWriteDown	7376000	USD
CY2009	us-gaap	Inventory Write Down InventoryWriteDown	8760000	USD
CY2010	ofix	Debt Refinancing Charge DebtRefinancingCharge	550000	USD
CY2010	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1254000	USD
CY2010	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	24215000	USD
CY2010	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	517000	USD
CY2009	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1083000	USD
CY2009	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1852000	USD
CY2010	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	2222000	USD
CY2009	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	25000	USD
CY2010	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1778000	USD
CY2009	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2541000	USD
CY2010	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14770000	USD
CY2009	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	23858000	USD
CY2010	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	222000	USD
CY2009	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8941000	USD
CY2009	us-gaap	Gross Profit GrossProfit	407185000	USD
CY2010	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	230942000	USD
CY2009	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	215943000	USD
CY2010	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	88628000	USD
CY2009	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	88866000	USD
CY2010	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	7214000	USD
CY2009	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	12000	USD
CY2010	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2863000	USD
CY2009	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1310000	USD
CY2010	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-5289000	USD
CY2009	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	14537000	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25844000	USD
CY2009	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20915000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31008000	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2146000	USD
CY2009	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22287000	USD
CY2010	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7854000	USD
CY2009	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	70000	USD
CY2010	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	36269000	USD
CY2010	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30350000	USD
CY2009	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31460000	USD
CY2010	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5763000	USD
CY2009	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7041000	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	88990000	USD
CY2009	us-gaap	Operating Income Loss OperatingIncomeLoss	63875000	USD
CY2010	us-gaap	Investment Income Interest InvestmentIncomeInterest	330000	USD
CY2009	us-gaap	Investment Income Interest InvestmentIncomeInterest	193000	USD
CY2010	us-gaap	Interest Expense InterestExpense	17228000	USD
CY2009	us-gaap	Interest Expense InterestExpense	24820000	USD
CY2010	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-398000	USD
CY2009	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1079000	USD
CY2010	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16592000	USD
CY2009	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-23854000	USD
CY2010	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	72398000	USD
CY2009	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	40021000	USD
CY2010	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28190000	USD
CY2009	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	28323000	USD
CY2010	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4266000	USD
CY2010	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	1723000	USD
CY2009	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	248000	USD
CY2009	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15549000	USD
CY2010	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.51
CY2009	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.43
CY2010	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.47
CY2009	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.42
CY2010	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17601956	shares
CY2009	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17119474	shares
CY2010	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17913545	shares
CY2009	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17202943	shares
CY2010	us-gaap	Sales Revenue Net SalesRevenueNet	564370000	USD
CY2009	us-gaap	Sales Revenue Net SalesRevenueNet	545635000	USD
CY2010	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	131716000	USD
CY2009	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	138450000	USD
CY2010	us-gaap	Gross Profit GrossProfit	432654000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	20703000	USD
CY2011	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11816000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	32519000	USD
CY2010	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-11290000	USD
CY2009	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-612000	USD
CY2009	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	1143000	USD
CY2010	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	2222000	USD
CY2009	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	25000	USD
CY2009	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	220000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13664000	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40026000	USD
CY2009	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-29955000	USD
CY2010	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-103000	USD
CY2009	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	394000	USD
CY2010	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	233000	USD
CY2009	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1266000	USD
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22521000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13328000	USD
CY2008Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14594000	USD
CY2010	us-gaap	Interest Paid Net InterestPaidNet	16032000	USD
CY2009	us-gaap	Interest Paid Net InterestPaidNet	26724000	USD
CY2010	us-gaap	Income Taxes Paid IncomeTaxesPaid	29743000	USD
CY2009	us-gaap	Income Taxes Paid IncomeTaxesPaid	17665000	USD
CY2009	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22344000	USD
CY2010	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	471000	USD
CY2009	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	7006000	USD
CY2009	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28776000	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Reallocation Of Minority Interest AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest	-1143000	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	25000	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10752000	USD
CY2009	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18000	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	240269000	USD
CY2010	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1710000	USD
CY2010	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	42408000	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	2222000	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8138000	USD
CY2010	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7854000	USD
CY2011Q4	ofix	Operating Loss Carryforwards State And Local OperatingLossCarryforwardsStateAndLocal	23700000	USD

Files In Submission

Name	View Source	Status
0001104659-12-014637-index-headers.html	Edgar Link	pending
0001104659-12-014637-index.html	Edgar Link	pending
0001104659-12-014637.txt	Edgar Link	pending
0001104659-12-014637-xbrl.zip	Edgar Link	pending
a12-4033_110k.htm	Edgar Link	pending
a12-4033_1ex10d5.htm	Edgar Link	pending
a12-4033_1ex21d1.htm	Edgar Link	pending
a12-4033_1ex23d1.htm	Edgar Link	pending
a12-4033_1ex31d1.htm	Edgar Link	pending
a12-4033_1ex31d2.htm	Edgar Link	pending
a12-4033_1ex32d1.htm	Edgar Link	pending
a12-4033_1ex32d2.htm	Edgar Link	pending
a12-4033_1ex3d2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g40331bc11i001.gif	Edgar Link	pending
ofix-20111231.xml	Edgar Link	completed
ofix-20111231.xsd	Edgar Link	pending
ofix-20111231_cal.xml	Edgar Link	unprocessable
ofix-20111231_def.xml	Edgar Link	unprocessable
ofix-20111231_lab.xml	Edgar Link	unprocessable
ofix-20111231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OFIX
Orthofix Medical Inc. Stock $ofix

2011 Form 10-K Financial Statement

#000110465912014637 Filed on February 29, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX Orthofix Medical Inc. Stock $ofix

2011 Form 10-K Financial Statement

#000110465912014637 Filed on February 29, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX
Orthofix Medical Inc. Stock $ofix